3D Bioprinting Regulations: a UK/EU Perspective
暂无分享,去创建一个
Abstract This report introduces the challenges 3D bioprinting poses to the existing legal regime across bioethics, safety, regenerative medicine, and tissue engineering. We briefly review the 3D bioprinting technology and look into the relevant regulatory instruments for the pre-printing, printing, and post-printing stages. Special attention is paid to the applications of the EU Advanced Therapy Medicinal Products Regulation and the new Medical Device Regulation.
[1] A. Cronin,et al. The Human Transplantation (Wales) Act 2013: An Act of Encouragement, Not Enforcement , 2015 .
[2] David J. Williams,et al. A 3D bioprinting exemplar of the consequences of the regulatory requirements on customized processes. , 2015, Regenerative medicine.